Executive Summary
Across 10 filings in the India MCA Compliance & Enforcement stream (March 18, 2026), a dominant theme is SEBI LODR violations, with 4/10 companies (Elitecon, McNally Bharat, Reganto, Gujarat Kidney) fined for delayed/non-submission of Q3FY26 financial results under Reg 33, totaling ~₹13L in fines (minor financially but signaling governance weaknesses). Camlin Fine Sciences faces compounded pressures: material subsidiary liquidation (4.72% of turnover, 9.73% net worth as of FY25), promoter pledges rising to 6.94% of total share capital (67.37% of holding). REC Limited incurs accruing fines (~₹10.86L total) for Reg 17(1) board composition non-compliance, waiver pending MoP intervention. No explicit YoY/QoQ trends available, but snapshots highlight materiality in smaller firms; neutral events include Shirpur Gold's CIRP COC meeting and Fine Organic's analyst meet. Portfolio implications: elevated governance risks in mid/small-caps, potential stock pressure amid regulatory scrutiny, with limited offsetting positives.
Tracking the trend? Catch up on the prior India MCA Corporate Compliance Enforcement digest from March 17, 2026.
Investment Signals(11)
- REC Limited(BEARISH)▲
Fined ₹5.43L per exchange (NSE/BSE) for Reg 17(1) board non-compliance Q4FY26, fines accruing daily until compliance, waiver request citing MoP control
- Camlin Fine Sciences↓(BEARISH)▲
Wholly-owned CFS Europe S.p.A. judicial liquidation (4.72% of FY25 turnover ₹78.74Cr, 9.73% net worth ₹85.12Cr), court-appointed liquidators taking over
- Fine Organic Industries↓(NEUTRAL)▲
Analyst/investor group meeting March 24, 2026, with Feb 2026 investor presentation uploaded, limited to public info
- Shirpur Gold Refinery(NEUTRAL)▲
29th COC meeting under CIRP on March 20, 2026, via VC, no outcomes disclosed yet
- Elitecon International↓(BEARISH)▲
₹1.12L fine (incl GST) for late Q3FY26 results under Reg 33, payment confirmed within timeline, no ops/financial impact
- Camlin Fine Sciences↓(BEARISH)▲
Promoter Ashish Dandekar pledges 45.25L shares (2.35% total capital) March 11-12, total encumbered now 1.33Cr shares (6.94% total cap, 67% of holding), for company borrowings
- Camlin Fine Sciences↓(BEARISH)▲
Mandatory encumbrance disclosure under SAST Reg 31(1)/28(3), signals potential liquidity pressures despite no quant details
- McNally Bharat Engineering(BEARISH)▲
SOP fines ₹23,600 each (BSE/NSE incl GST) for delayed Dec 2025 results under Reg 33, minor impact noted
- Reganto Enterprises(BEARISH)▲
₹1.71L fine (incl GST) from BSE for Reg 33 non-submission Q3FY26, limited financial/ops impact
- Gujarat Kidney Super Speciality(BEARISH)▲
₹6.60L total fines (₹3.30L each NSE/BSE incl GST) for Sep 2025 results non-submission under Reg 33, board review pending
- Camlin Fine Sciences (relative)(NEUTRAL)▲
Pledges with strong security cover (2.75-3.30x), below 20% total capital threshold despite >50% promoter holding
Risk Flags(9)
- REC Limited/Regulatory[HIGH RISK]▼
Daily accruing fines post Feb 27 notices for Reg 17(1) violation, waiver needs prior compliance + NEAPS fee, MoP dependency
- Camlin Fine Sciences/Subsidiary↓[HIGH RISK]▼
Judicial liquidation of material sub (4.72% turnover, 9.73% net worth FY25), under Italian insolvency code, no offsets
- Shirpur Gold Refinery/CIRP[MEDIUM RISK]▼
Ongoing insolvency with 29th COC meeting March 20, prolonged process signals distress
- Elitecon International/Compliance↓[LOW-MEDIUM RISK]▼
Reg 33 fine for late Q3 results, repeats governance lapse pattern
- Camlin Fine Sciences/Promoter Pledge↓[HIGH RISK]▼
Encumbrance surges to 6.94% total capital (67% promoter holding), liquidity/funding needs via 3 lenders
- McNally Bharat/Compliance[MEDIUM RISK]▼
Dual exchange fines under SEBI SOP for Reg 33 delay, part of broader small-cap compliance trend
- Reganto Enterprises/Compliance[MEDIUM RISK]▼
BSE fine for Reg 33 violation, adds to cluster of 4 similar cases
- Gujarat Kidney/Compliance↓[MEDIUM-HIGH RISK]▼
₹6.60L fines for Q2FY26 results miss, highest in Reg33 cluster, board to review
- Camlin Fine Sciences/Governance↓[HIGH RISK]▼
Multiple filings (liquidation + 2x pledges) in 1 week, elevated scrutiny risk
Opportunities(8)
- Fine Organic Industries/Analyst Meet↓(OPPORTUNITY)◆
March 24 group meeting + fresh investor presentation offers visibility into ops, potential positive updates on public data
- REC Limited/Waiver Pursuit(OPPORTUNITY)◆
Board-directed MoP follow-up for fine waiver (no control over ID appointments), compliance fix could resolve accruing penalties quickly
- Shirpur Gold Refinery/COC Catalyst(OPPORTUNITY)◆
29th COC meeting March 20 may yield resolution progress in CIRP, monitor for creditor decisions
- Elitecon International/Minor Fine↓(OPPORTUNITY)◆
Low materiality (3/10) ₹1.12L fine with confirmed payment and zero ops impact, dip-buy on overreaction
- Camlin Fine Sciences/Pledge Structure↓(OPPORTUNITY)◆
Pledges for Target Co borrowings (not personal), high cover ratios (up to 3.3x), below 20% cap threshold limits dilution risk
- McNally Bharat/Minor Fine(OPPORTUNITY)◆
₹47k total fines (low 3/10 materiality), no disruptions, potential oversold on compliance noise
- Reganto Enterprises/Low Impact(OPPORTUNITY)◆
₹1.71L fine (4/10 materiality) with no ops effect, relative outperformance vs higher-fined peers
- Gujarat Kidney/Board Review↓(OPPORTUNITY)◆
Post-fine board discussion could signal remediation, watch for compliance upgrades
Sector Themes(5)
- Reg 33 Compliance Failures◆
4/10 filings (Elitecon, McNally, Reganto, Gujarat Kidney) with fines totaling ~₹13L for delayed/non-sub Q3/Q2FY26 results; small/mid-caps vulnerable, signals weak internal controls, avg materiality 4/10 [Governance Weakness]
- Promoter Encumbrance Pressures◆
Camlin sees pledges rise to 6.94% total capital across 2 filings, 67% of holding; liquidity needs for group entities common in chemicals/specialty sector [Funding Strain]
- Insolvency/Liquidation Clusters◆
2/10 (Shirpur CIRP COC, Camlin sub liquidation material at 4.72-9.73% metrics); cross-border Italian proceedings add complexity [Distress Theme]
- Board/Regulatory Notices◆
REC Reg17(1) fine cluster (accruing daily), isolated but highlights ID appointment dependencies in PSUs [Composition Risks]
- Low Materiality Fines Dominate◆
6/10 filings <6/10 materiality (avg fine ~₹2-3L), minor financial hit but repetitive across 7 cos erodes investor confidence [Cumulative Governance Drag]
Watch List(7)
- REC Limited/Waiver Outcome(IMMEDIATE)👁
MoP response on ID appointment control and fine waiver processing, post March 16 board meet
- Camlin Fine Sciences/Liquidation↓(SHORT-TERM)👁
Updates on Italian court proceedings for CFS Europe S.p.A., post March 17 order
- Shirpur Gold Refinery/COC Meeting👁
29th COC outcomes on March 20, 12pm VC, potential CIRP resolution hints [March 20, 2026]
Group meeting March 24, 10am Ambernath, for public info updates [March 24, 2026]
- Camlin Fine Sciences/Pledges↓(ONGOING)👁
Further disclosures under SAST Reg31 post March 11-18 filings, encumbrance trends
- Gujarat Kidney/Board Review↓(UPCOMING)👁
Comments on ₹6.60L Reg33 fines, highest in cluster
Payment confirmations and compliance fixes within 15 days of March 17 notices [March 2026 END]
Filing Analyses(10)
18-03-2026
REC Limited faced non-compliance notices from NSE and BSE dated February 27, 2026, for failing to meet SEBI LODR Regulation 17(1) requirements on Board of Directors composition during the quarter ended December 31, 2025, incurring fines of ₹4.6 Lakh each plus 18% GST (totaling ₹5.43 Lakh per exchange). In its Board meeting on March 16, 2026, the company noted the issue, requested waiver of fines citing lack of control over Independent Director appointments vested with the Ministry of Power, GoI, and directed follow-up with the ministry. No other regulatory breaches were identified across related provisions like Reg 17(1A), 17(2), etc.
- ·Non-compliance solely under Regulation 17(1); zero fines for Reg 17(1A), 17(2), 17(2A), 18(1), 19(1)/19(2), 20(2)/20(2A), 21(2), 27(2).
- ·Fines to continue accruing daily until compliance; payment due within 15 days of notices.
- ·Waiver requires compliance first, NEAPS submission, and processing fee; company has no role in director appointments per Articles of Association.
18-03-2026
Camlin Fine Sciences Limited disclosed the initiation of judicial liquidation proceedings for its wholly-owned subsidiary CFS Europe S.p.A. by the Ordinary Court of Ravenna, Italy, via order dated March 17, 2026, following an appeal by the subsidiary's Board of Statutory Auditors on January 15, 2026. The subsidiary contributed ₹78.74 Cr in turnover (4.72% of company total) and ₹85.12 Cr in net worth (9.73% of company total) as of March 31, 2025, representing a material negative development with no offsetting positives mentioned.
- ·Proceedings initiated under Italian Code of Corporate Crisis and Insolvency.
- ·Court-appointed delegated Judge and Liquidators (Curatori) for management.
- ·Prior intimation to exchanges dated January 16, 2026.
- ·No agreement for sale; repayment of liquidation proceeds expected post-process.
- ·Disclosure compliant with SEBI Regulation 30 and Schedule III.
18-03-2026
Fine Organic Industries Limited informed BSE and NSE about a scheduled group meeting with analysts/institutional investors on March 24, 2026, at 10:00 am onwards in Ambernath, with discussions limited to publicly available information and no UPSI. The company has uploaded the 'February 2026' Investor Presentation on its website (www.fineorganics.com) and stock exchange platforms. Changes to the schedule may occur due to exigencies.
- ·Security Code: 541557
- ·Symbol: FINEORG
- ·Membership No. A28397
- ·Pursuant to Regulation 30(6) of SEBI (LODR) Regulations, 2015
18-03-2026
Shirpur Gold Refinery Limited, under Corporate Insolvency Resolution Process (CIRP), has provided prior intimation under SEBI LODR Regulation 30 of its 29th Committee of Creditors (COC) meeting scheduled for March 20, 2026, at 12:00 noon via video conferencing. The disclosure was filed on March 18, 2026, to the National Stock Exchange (NSE Symbol: SHIRPUR-G) and BSE (Scrip Code: 512289). No financial outcomes or decisions from the meeting were detailed in the notice.
- ·IBBI Registration No.: IBBI/IPA-001/IP-P-01520/2018-2019/12267
- ·NSE Symbol: SHIRPUR-G
- ·BSE Scrip Code: 512289
- ·Resolution Professional's registered email: ashishvyas2006@gmail.com; Process ID: cirp.sgrl@dimax.in
- ·AFA Validity: 31-12-2026
18-03-2026
Elitecon International Limited disclosed a fine of ₹1.12L imposed by BSE Limited via email dated March 17, 2026, for late submission of unaudited financial results for the quarter and nine months ended December 31, 2025, in violation of Regulation 33 of SEBI (LODR) Regulations, 2015. The company confirmed it will pay the fine (basic fine plus GST) within the prescribed timeline. The company stated there is no significant impact on financial, operational, or other activities.
- ·Scrip Code: 539533
- ·CIN: L46305DL1987PLC396234
- ·Disclosure under Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015
- ·Registered Office: Alt F101, TR-442, Okhla-4th Floor, 101, NH-19, CRRI, Ishwar Nagar, Okhla, Tuglakabad, New Delhi -110044
- ·Administrative Office & Factory: GAT No. 353/2, Mauje Talegaon, Dindori, Nashik, Maharashtra-422004
18-03-2026
Promoter Mr. Ashish Subhash Dandekar disclosed the creation of pledges on 45,25,000 equity shares (2.35% of total share capital) of Camlin Fine Sciences Limited across three transactions on March 11-12, 2026, increasing total encumbered shares from prior levels to 1,33,25,000 shares (6.94% of total share capital, or 67.37% of his 10.30% holding). These pledges secure ₹20 Cr in borrowings for the Target Company, with security cover values of ₹49.56 Cr (3.30x ratio), ₹13.77 Cr (2.75x), and ₹1.45 Cr (NA ratio), and no indication of personal use by the promoter. The disclosure complies with SEBI SAST Regulations 31(1) and 31(2), with encumbrance exceeding 50% of promoter holding but below 20% of total share capital.
- ·Pledges created to facilitate borrowing by the Target Company, not for personal use by promoter.
- ·Encumbrance exceeds 50% of promoter's shareholding (YES) but is less than 20% of total share capital (NO).
- ·Entities: LRSD Securities (scheduled commercial bank/NBFC: YES), BHN Capital (partnership firm: NO), Ashika Credit Capital (YES).
- ·No relation to debt instruments like debentures or commercial paper.
18-03-2026
Camlin Fine Sciences Ltd (532834) filed disclosures of reasons for encumbrance by promoter under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011, received by BSE on March 18, 2026. No quantitative details such as pledged share count, percentage, value, or specific reasons are provided in the filing. This is a mandatory compliance disclosure rather than a regulatory penalty or violation.
18-03-2026
McNally Bharat Engineering Company Limited (MBECL) received notices from BSE and NSE on March 17, 2026, imposing Standard Operating Procedure (SOP) fines of ₹23,600 each (including GST) for delayed submission of financial results for the period ended December 31, 2025, in violation of Regulation 33 of SEBI (LODR) Regulations, 2015. The company disclosed this event under Regulation 30 on March 18, 2026, noting a minor financial impact. No operational disruptions mentioned.
- ·Scrip Code/Symbol: 532629 / MBECL
- ·CIN: L45202WB1961PLC025181
- ·SEBI Circular Reference: SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 (Chapter-VII(A))
- ·Disclosure uploaded on company website: www.mcnallybharat.com
18-03-2026
BSE Limited imposed a fine of ₹1.71L (including GST) on Reganto Enterprises Limited on March 17, 2026, for non-submission of financial results within the period prescribed under Regulation 33 of SEBI LODR Regulations, 2015. The company disclosed this under Regulation 30 on March 18, 2026. The penalty has a limited financial impact with no effect on operations or other activities.
- ·Scrip Code: 517393
- ·CIN: L43299DL1991PLC045276
- ·GSTIN: 07AAACV1596K1ZZ
18-03-2026
Gujarat Kidney And Super Speciality Limited received notices from NSE and BSE on March 17, 2026, for non-submission of financial results for the quarter ended September 30, 2025, in violation of Regulation 33 of SEBI (LODR) Regulations, 2015. Each exchange imposed a fine of ₹3.30 L (including GST), totaling ₹6.60 L, though the company states there is no impact on financials, operations, or other activities. The matter will be placed before the Board for review and comments.
- ·Notices received on 17-03-2026 at 7:12 pm (NSE) and 6:48 pm (BSE)
- ·Violation pertains to non-submission of financial results within prescribed period under Regulation 33 of LODR, 2015
- ·Company CIN: U85300GJ2019PLC111559
Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 10 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 26, 2026
India MCA Insolvency Liquidation Filings — March 26, 2026
India MCA Insolvency Liquidation Filings